Eupraxia Pharmaceuticals, Inc. (EPRX)
7.50
+0.05
(+0.67%)
USD |
NASDAQ |
Sep 03, 16:00
7.50
0.00 (0.00%)
After-Hours: 20:00
Eupraxia Pharmaceuticals Total Assets (Quarterly) : 139.91M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 139.91M |
| March 31, 2026 | 145.35M |
| December 31, 2025 | 86.15M |
| September 30, 2025 | 92.35M |
| June 30, 2025 | 23.60M |
| March 31, 2025 | 29.23M |
| December 31, 2024 | 34.94M |
| September 30, 2024 | 10.36M |
| June 30, 2024 | 24.98M |
| March 31, 2024 | 36.64M |
| December 31, 2023 | |
| September 30, 2023 | 25.41M |
| June 30, 2023 | 15.38M |
| March 31, 2023 | 14.69M |
| Date | Value |
|---|---|
| December 31, 2022 | 19.10M |
| September 30, 2022 | 22.89M |
| June 30, 2022 | 28.73M |
| March 31, 2022 | 21.78M |
| December 31, 2021 | 24.72M |
| September 30, 2021 | 27.56M |
| June 30, 2021 | 29.99M |
| March 31, 2021 | 25.91M |
| December 31, 2020 | 1.141M |
| September 30, 2020 | 0.6892M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 2.533M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Edesa Biotech, Inc. | 12.72M |
| ProMIS Neurosciences, Inc. | 56.69M |
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 10.23M |
| Shareholders Equity (Quarterly) | 131.28M |
| Debt to Equity Ratio | 0.014 |
| Current Ratio | 16.00 |
| Net Debt Paydown Yield | -0.08% |